Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/105596
Type: Journal article
Title: A biodegradable polyurethane dermal matrix in reconstruction of free flap donor sites: a pilot study
Author: Wagstaff, M.
Schmitt, B.
Coghlan, P.
Finkemeyer, J.
Caplash, Y.
Greenwood, J.
Citation: Eplasty: open access journal of plastic and reconstructive surgery, 2015; 15:102-118
Publisher: PubMed Central
Issue Date: 2015
ISSN: 1937-5719
1937-5719
Statement of
Responsibility: 
Marcus J.D. Wagstaff, Bradley J. Schmitt, Patrick Coghlan, James P. Finkemeyer, Yugesh Caplash and John E. Greenwood
Abstract: We have developed a biodegradable temporizing matrix (BTM) capable of supporting secondary split-skin graft-take in animal studies. We report its first long-term implantation and use as a dermal scaffold in humans. This preliminary study assesses its ability to integrate, its ease of delamination, its ability to sustain split-skin graft in complex wounds, the degree of wound contraction, and ultimately the quality of the scar at 1 year postimplantation. Ten patients were recruited, each requiring elective free flap reconstruction. Free flap donor sites created were anterolateral thigh flaps, fibular osseocutaneous flaps, or radial/ulnar forearm (RF/UF) flaps. The BTM was implanted when the flap was detached from its donor site. Dressing changes were performed twice weekly. The time elapsed between implantation and delamination depended on the type of flap and thus the wound bed left. Once integrated, the BTMs were delaminated in theatre, and the surface of the "neodermis" was refreshed by dermabrasion, prior to application of a split-skin graft. The BTM integration occurred in all patients (100% in 6 patients, with 90%, 84%, 76%, and 60% integration in the remainder). Integrated BTM sustained successful graft-take in all patients. Complete take was marred in 2 patients, over areas of BTM that had not integrated and graft application was performed too early. The BTM can be applied into wounds in humans and can integrate, persist in the presence of infection, and sustain split-skin overgrafting, despite the trial group presenting with significant comorbidities.
Keywords: biodegradable polyurethane
dermal scaffold
free flap donor site
reconstruction
synthetic dermal matrix
Rights: Copyright © 2015 The Author(s) This is an open-access article whereby the authors retain copyright of the work. The article is distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Published version: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412164/
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_105596.pdfPublished Version1.26 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.